Quick Takeaways
- Logos Global Management LP filed SCHEDULE 13D/A for Olema Pharmaceuticals, Inc. Common Stock (OLMA).
- Disclosed ownership: 4.7%.
- Date of event: 18 Mar 2025.
Logos Global Management LP - 18 Mar 2025 SCHEDULE 13D/A Report for Olema Pharmaceuticals, Inc. Common Stock (OLMA)
- Filing Manager
- Logos Global Management LP
- Reporting Manager
- Logos Global Management LP
- Symbol
- OLMA
- Shares outstanding
- 68,273,936 shares
- Disclosed Ownership
- 3,208,875 shares
- Ownership
- 4.7%
- Form type
- SCHEDULE 13D/A
- Filing time
- 13 May 2025, 19:29:56 UTC
- Date of event
- 18 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Logos Global Management LP disclosed 4.7% ownership in Olema Pharmaceuticals, Inc. Common Stock (OLMA) on 18 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 May 2025, 19:29.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (6)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Logos Global Management LP | 4.7% | 3,208,875 | 0 | 3,208,875 | /s/ Arsani William | Managing Partner | 0001792126 |
| Logos Global Management GP LLC | 4.7% | 3,208,875 | 0 | 3,208,875 | /s/ Arsani William | Managing Member | |
| Arsani William | 4.7% | 3,208,875 | 0 | 3,208,875 | /s/ Arsani William | Reporting person | 0001848372 |
| Graham Walmsley | 4.7% | 3,208,875 | 0 | 3,208,875 | /s/ Graham Walmsley | Reporting person | 0001777517 |
| Logos Opportunities GP LLC | 1% | 708,114 | 0 | 708,114 | /s/ Arsani William | Managing Member | |
| Logos GP LLC | 3.7% | 2,508,114 | 0 | 2,508,114 | /s/ Arsani William | Managing Member |